Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (23)

Search Parameters:
Keywords = Gentiana lutea

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
16 pages, 2164 KiB  
Article
The Hepatoprotective Properties of Gentiopicroside, Sweroside, and Swertiamarin Against Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
by Anthony O. Boateng, Vinood B. Patel and S. W. Annie Bligh
Biomolecules 2025, 15(5), 726; https://doi.org/10.3390/biom15050726 - 16 May 2025
Viewed by 910
Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a metabolic disease characterised by the accumulation of fat in the liver. It is estimated that 30–38% of the world’s adult population have MASLD, making it the most prevalent global chronic liver disease. Due to a [...] Read more.
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a metabolic disease characterised by the accumulation of fat in the liver. It is estimated that 30–38% of the world’s adult population have MASLD, making it the most prevalent global chronic liver disease. Due to a lack of a therapy for MASLD, treatment has been mainly focussed on managing the conditions associated with the disease such as obesity, diabetes mellitus, and hyperlipidaemia. This study aimed to investigate the role played by Gentiana phytochemicals including the following: gentiopicroside, sweroside, and swertiamarin, in promoting hepatocyte protection against the cytotoxic effects of fatty acids. Gentiana species such as lutea, macrophylla, rigescens, and scabra are known to protect and enhance hepatocyte viability via their antioxidant, anti-inflammatory, and bitter components including the following: amarogentin gentianine, iso-orientin, swertiamarin, gentiopicroside, and sweroside. In this study, HepG2 cells pre-treated with phytochemicals gentiopicroside, sweroside, swertiamarin, and silymarin followed by an exposure to arachidonic acid (10, 30, 50 and 80 µM) were assessed for cell viability via MTT, mitochondrial function via seahorse assay, ROS levels via DCF assay, and annexin V-FITC for apoptosis. THLE-2 cells were also assayed for validation. The phytochemicals tested improved ATP production notably gentiopicroside, which improved ATP production by over 60% compared to untreated hepatocytes. Significant hepatocyte protection against lipotoxicity leading to apoptosis was also observed in gentiopicroside in the presence of 30 µM arachidonic acid with apoptosis reduced by over 50%. ROS production was reduced up to 60% by the pre-treatment of HepG2 cells with 20 µM, gentiopicroside, sweroside, swertiamarin, and silymarin, with the highest reduction observed in swertiamarin. It was concluded that phytochemicals gentiopicroside, sweroside, and swertiamarin play key roles in the hepatocyte protection against the cytotoxic effects of fatty acids. This protection is conferred by enhancing mitochondrial function in terms of increasing the maximal respiratory capacity in response to a high influx of fatty acids, promoting ATP production as well as scavenging ROS produced as a result of high fatty acid influx and increased mitochondrial respiration. Highlights: Gentiopicroside may minimise lipotoxicity leading to apoptosis and necrosis in hepatocytes in the presence of arachidonic acid. A pre-treatment of hepatocytes with phytochemicals, namely gentiopicroside, sweroside, and silymarin provides a degree of protection which may be attributed to the enhancement of mitochondrial function. Sweroside, silymarin, and swertiamarin may protect HepG2 and THLE-2 cells by scavenging ROS produced by arachidonic acid and the mitochondrial electron transport chain. Full article
Show Figures

Figure 1

28 pages, 4709 KiB  
Article
Dual-Mechanism Gastroretentive Tablets with Encapsulated Gentian Root Extract
by Jelena Mudrić, Ljiljana Đekić, Nemanja Krgović, Đorđe Medarević, Katarina Šavikin, Milica Radan, Nada Ćujić Nikolić, Tijana Ilić, Bojana Vidović and Jelena Đuriš
Pharmaceutics 2025, 17(1), 71; https://doi.org/10.3390/pharmaceutics17010071 - 7 Jan 2025
Viewed by 1185
Abstract
Background/Objectives: This study aimed to develop gastroretentive tablets based on mucoadhesive–floating systems with encapsulated gentian (Gentiana lutea, Gentianaceae) root extract to overcome the low bioavailability and short elimination half-life of gentiopicroside, a dominant bioactive compound with systemic effect. The formulation also [...] Read more.
Background/Objectives: This study aimed to develop gastroretentive tablets based on mucoadhesive–floating systems with encapsulated gentian (Gentiana lutea, Gentianaceae) root extract to overcome the low bioavailability and short elimination half-life of gentiopicroside, a dominant bioactive compound with systemic effect. The formulation also aimed to promote the local action of the extract in the stomach. Methods: Tablets were obtained by direct compression of sodium bicarbonate (7.5%) and solid lipid microparticles (92.5%), which were obtained with lyophilizing double emulsions. A quality by design (QbD) was employed to evaluate the impact of formulation factors and processing parameters on emulsion viscosity, powder characteristics (moisture content, encapsulation efficiency, flowability), and tablet characteristics (floating lag time, gentiopicroside release, and assessment of dispersibility during in vitro dissolution). Results: The trehalose content and high-shear-homogenization (HSH) time of primary emulsion were critical factors. Trehalose content positively influenced emulsion viscosity, moisture content, floating lag time, encapsulation efficiency, and the release rate of gentiopicroside. HSH time positively affected powder stability and negatively gentiopicroside release. The selected powder had a high gentiopicroside encapsulation efficiency (95.13%), optimal stability, and good flowability. The developed tablets exhibited adequate floating lag time (275 s), mucoadhesive properties, and gentiopicroside biphasic release (29.04% in 45 min; 67.95% in 6 h). Furthermore, the optimal tablet formulation remained stable for 18 months and was primarily digested by duodenal enzymes. Conclusions: Dual-mechanism gastroretentive tablets with encapsulated gentian root extract were successfully developed. The in vitro digestion study demonstrated that the optimal formulation effectively resisted gastric enzymes, ensuring the release of its contents in the small intestine, even in the case of premature gastric evacuation. Full article
(This article belongs to the Special Issue Drug Delivery for Natural Extract Applications)
Show Figures

Graphical abstract

15 pages, 3744 KiB  
Article
Hot Spots of Bitter Compounds in the Roots of Gentiana lutea L. subsp. aurantiaca: Wild and Cultivated Comparative
by Óscar González-López, Álvaro Rodríguez-González, Carmelo García Pinto, Julia Arbizu-Milagro and Pedro A. Casquero
Agronomy 2024, 14(5), 1068; https://doi.org/10.3390/agronomy14051068 - 17 May 2024
Cited by 1 | Viewed by 1940
Abstract
Gentiana lutea L. subsp. aurantiaca M. Lainz is a plant endemic to the north-western mountainous areas of the Iberian Peninsula. Its roots are widely used mainly because of the high content of bitter compounds. The occurrence of these valuable bitter compounds in the [...] Read more.
Gentiana lutea L. subsp. aurantiaca M. Lainz is a plant endemic to the north-western mountainous areas of the Iberian Peninsula. Its roots are widely used mainly because of the high content of bitter compounds. The occurrence of these valuable bitter compounds in the roots is rather inhomogeneous, resulting in fluctuating root quality. Methanolic extracts obtained from different parts and tissues of wild and cultivated gentian, in and out of its natural environment, were analysed using HPLC chromatography to investigate the variation in the concentration of amarogentin, gentiopicroside, sweroside and swertiamarin. The distribution patterns of these compounds in the different analysed fractions showed that the concentration of bitter compounds varies significantly. Amarogentin is much more highly concentrated in the secondary roots, and all of the analysed compounds were found in a significantly higher content in the root cortex than in the vascular tissues. Roots cultivated in the natural habitat showed much higher concentrations in amarogentin and more biomass, while in those cultivated out of the natural environment, sweroside concentration was higher. These results allow us to understand that, when cultivated, the variability in the concentration of the different bitter compounds is linked with the edaphoclimatic conditions, but more importantly that it is linked with the dominating kind of tissues and the root system structure, especially when analysing the content of amarogentin and sweroside. The selection of plants with an optimal root system structure for breeding may increase the yield in bitter compounds and contribute to developing the commercial cultivation of this protected plant. Full article
Show Figures

Figure 1

42 pages, 2359 KiB  
Review
Nutraceutical Aspects of Selected Wild Edible Plants of the Italian Central Apennines
by Francesca Fantasma, Vadym Samukha, Gabriella Saviano, Maria Giovanna Chini, Maria Iorizzi and Claudio Caprari
Nutraceuticals 2024, 4(2), 190-231; https://doi.org/10.3390/nutraceuticals4020013 - 9 Apr 2024
Cited by 9 | Viewed by 4634
Abstract
All over the world, wild edible plants are an essential source of chemical components that justify their use in folk medicine. The aim of this review is to document and summarize the knowledge of ten wild plants analyzed in a previous study for [...] Read more.
All over the world, wild edible plants are an essential source of chemical components that justify their use in folk medicine. The aim of this review is to document and summarize the knowledge of ten wild plants analyzed in a previous study for their ethnomedical significance. Achillea millefolium, Borago officinalis, Foeniculum vulgare, Gentiana lutea, Juniperus communis, Laurus nobilis, Malva sylvestris, Satureja montana, Silybum marianum and Urtica dioica were the subjects of our study. They are commonly found in the central Italian Apennines and the Mediterranean basin. Phytochemicals contained in wild plants, such as phenols, polyphenols, flavonoids, condensed tannins, carotenoids, etc., are receiving increasing attention, as they exert a wide range of biological activities with resulting benefits for human health. Based on the 353 studies we reviewed, we focused our study on the following: (a) the ethnobotanical practices and bioactive phytochemicals; (b) the composition of polyphenols and their role as antioxidants; (c) the methodologies commonly used to assess antioxidant activity; (d) the most advanced spectroscopic and spectrometric techniques used to visualize and characterize all components (metabolomic fingerprinting). The potential of pure compounds and extracts to be used as nutraceuticals has also been highlighted through a supposed mechanism of action. Full article
(This article belongs to the Special Issue Functional Foods as a New Therapeutic Strategy 2.0)
Show Figures

Figure 1

18 pages, 1943 KiB  
Article
Spasmolytic Activity of Gentiana lutea L. Root Extracts on the Rat Ileum: Underlying Mechanisms of Action
by Nemanja Kitić, Jelena Živković, Katarina Šavikin, Milica Randjelović, Miloš Jovanović, Dušanka Kitić, Bojana Miladinović, Milica Milutinović, Nenad Stojiljković and Suzana Branković
Plants 2024, 13(3), 453; https://doi.org/10.3390/plants13030453 - 4 Feb 2024
Cited by 3 | Viewed by 2237
Abstract
The roots of Gentiana lutea L. are utilized in the preparation of various beverages and herbal remedies, serving as a traditional remedy for gastrointestinal ailments. The spasmolytic activity that could substantiate the traditional use of G. lutea root had not been investigated. The [...] Read more.
The roots of Gentiana lutea L. are utilized in the preparation of various beverages and herbal remedies, serving as a traditional remedy for gastrointestinal ailments. The spasmolytic activity that could substantiate the traditional use of G. lutea root had not been investigated. The main objective goal of the study was to determine the validity of its use as a traditional remedy. The extraction of G. lutea root was performed using a 50% hydroethanolic solvent with three different extraction techniques: ultrasound-assisted extraction (UAE), heat-assisted extraction, and percolation. The spasmolytic activity was tested on isolated rat ileum. The mechanism of action was monitored using the models of spontaneous contractions and acetylcholine-, histamine-, CaCl2-, Bay K8644-, L-NAME-, ODQ-, apamin-, BaCl2-, charybdotoxin-, glibenclamide-, TRAM-34-, and quinine-modified contractions. UAE, having the best bioactivity, was further subjected to a liquid–liquid extraction fractionation. HPLC phytochemical analysis was performed for all tested extracts and fractions. Gentian root extracts were rich in secoiridoids, xanthones, and flavonoids. The UAE has shown better results on spontaneous contractions in comparison to its fractions, leading to the more detailed testing of its spasmolytic mechanism of activity. The extract’s activity is primarily mediated through intermediate conductance Ca2+-activated K+ channels, ATP-sensitive K+ channels, voltage-sensitive K+ channels, and mechanisms that activate Ca2+ channels. Overall, the G. lutea root shows great potential in the treatment of spasmodic gastrointestinal ailments. Full article
Show Figures

Figure 1

14 pages, 3033 KiB  
Article
Beauvericin Immunotoxicity Prevention by Gentiana lutea L. Flower In Vitro
by Giacomo Di Matteo, Alessandra Cimbalo, Lara Manyes and Luisa Mannina
Toxins 2023, 15(9), 538; https://doi.org/10.3390/toxins15090538 - 31 Aug 2023
Viewed by 1854
Abstract
Beauvericin (BEA) is an emerging mycotoxin produced by some species of Fusarium genera that widely contaminates food and feed. Gentiana lutea is a protected medicinal plant known for its antioxidant and anti-inflammatory properties, which are attributed to its rich content of bioactive compounds. [...] Read more.
Beauvericin (BEA) is an emerging mycotoxin produced by some species of Fusarium genera that widely contaminates food and feed. Gentiana lutea is a protected medicinal plant known for its antioxidant and anti-inflammatory properties, which are attributed to its rich content of bioactive compounds. In order to evaluate the beneficial effects of G. lutea flower against BEA cytotoxicity, the aim of this study is to evaluate changes in protein expression after Jurkat cell exposure through a proteomics approach. To carry out the experiment, cells were exposed to intestinally digested G. lutea flower alone or in combination with the BEA standard (100 nM) over 7 days. Differentially expressed proteins were statistically evaluated (p < 0.05), revealing a total of 172 proteins with respect to the control in cells exposed to the BEA standard, 145 proteins for G. lutea alone, and 139 proteins when exposing the cells to the combined exposure. Bioinformatic analysis revealed processes implicated in mitochondria, ATP-related activity, and RNA binding. After careful analysis of differentially expressed proteins, it was evident that G. lutea attenuated, in most cases, the negative effects of BEA. Furthermore, it decreased the presence of major oncoproteins involved in the modulation of immune function. Full article
Show Figures

Figure 1

18 pages, 6651 KiB  
Article
Efficiency of Recovery of the Bioactive Principles of Plants by Comparison between Solid–Liquid Extraction in Mixture and Single-Vegetable Matrices via Maceration and RSLDE
by Daniele Naviglio, Marco Trifuoggi, Francesca Varchetta, Viviana Nebbioso, Angela Perrone, Laura Avolio, Eleonora De Martino, Domenico Montesano and Monica Gallo
Plants 2023, 12(16), 2900; https://doi.org/10.3390/plants12162900 - 9 Aug 2023
Cited by 10 | Viewed by 3427
Abstract
The term “officinal” derives from the Latin and includes all medicinal, aromatic and perfume plant species, which have long been a subject of interest for multiple purposes: health, food, pharmacological, cosmetic and so on. In this work, a study on six different species [...] Read more.
The term “officinal” derives from the Latin and includes all medicinal, aromatic and perfume plant species, which have long been a subject of interest for multiple purposes: health, food, pharmacological, cosmetic and so on. In this work, a study on six different species of medicinal plants, particularly characterized by digestive, choleretic and diuretic properties, was carried out: rosemary (Rosmarinus officinalis), sage (Salvia officinalis), laurel (Laurus nobilis), gentian (Gentiana lutea), dandelion (Taraxacum officinale) and rhubarb (Rheum palmatum). The roots and aerial parts of plants were separately extracted with two different techniques—maceration and rapid solid–liquid dynamic extraction (RSLDE)—and the quali/quantitative analysis of active ingredients have been determined by applying dry residue, Folin–Ciocalteu and DPPH assays. Data obtained have provided useful answers regarding the efficiency of the extraction carried out on a mixture or on single plants, allowing us to evaluate the best choice according to the cases and the final uses. Full article
(This article belongs to the Section Phytochemistry)
Show Figures

Figure 1

20 pages, 2524 KiB  
Review
Some European Gentiana Species Are Used Traditionally to Cure Wounds: Bioactivity and Conservation Issues
by Ardalan Pasdaran, Zheko Naychov, Daniela Batovska, Philip Kerr, Adrien Favre, Vladimir Dimitrov, Ina Aneva, Azadeh Hamedi and Ekaterina Kozuharova
Diversity 2023, 15(3), 467; https://doi.org/10.3390/d15030467 - 22 Mar 2023
Cited by 8 | Viewed by 4953
Abstract
Wound care will always be among the main tasks in all surgical specialties. Several medicinal plants have proven efficacy to cure wounds. Ethnobotanical research and ethnopharmacological research have virtually endless potential to find new lead compounds. The aim of this research review is [...] Read more.
Wound care will always be among the main tasks in all surgical specialties. Several medicinal plants have proven efficacy to cure wounds. Ethnobotanical research and ethnopharmacological research have virtually endless potential to find new lead compounds. The aim of this research review is to assess the potential of some Gentiana species as sources of promising active compounds to support wound healing. Gentians are among the most popular medicinal plants used in many countries for a wide spectrum of health conditions. Traditionally, those used to cure wounds are Gentiana lutea, G. punctata, G. asclepiadea, G. cruciata, G. oliverii, G. septemphida, and G. gelida. Candidate compounds with skin regeneration and wound-healing potential isolated from gentians are isogentisin, isoorientin, mangiferin, lupeol, pinoresinol, syringaresinol, eustomoside, and sweroside. Based on the rich source of traditional knowledge on the properties of gentians to cure various skin and soft tissue complications; only very few modern pharmacological studies have been performed to test this potential. Our review demonstrates that this field deserves further investigation. Many gentians are declining in number and have high IUCN conservation status, and cultivation and micropropagation methods are the only solution for the development of new drugs based on gentian extracts. Full article
(This article belongs to the Special Issue Ethnobotany, Medicinal Plants and Biodiversity Conservation)
Show Figures

Figure 1

13 pages, 1997 KiB  
Article
Development of a Novel Flavored Goat Cheese with Gentiana lutea Rhizomes
by Christian Coelho, Cécile Bord, Karine Fayolle, Cindy Bibang and Stéphanie Flahaut
Foods 2023, 12(3), 468; https://doi.org/10.3390/foods12030468 - 19 Jan 2023
Cited by 2 | Viewed by 2743
Abstract
Gentiana lutea rhizomes, generally used as a bittering agent in food, were harvested from two geographical sites (Massif Central: MC and Jura: J) to evaluate their potential use in the flavoring step during goat cheesemaking. Gentian flavored goat cheeses (MCGC and JGC) were [...] Read more.
Gentiana lutea rhizomes, generally used as a bittering agent in food, were harvested from two geographical sites (Massif Central: MC and Jura: J) to evaluate their potential use in the flavoring step during goat cheesemaking. Gentian flavored goat cheeses (MCGC and JGC) were elaborated by a one-night immersion of unflavored goat cheeses (CGC) into gentian-infused whey. The impregnation of gentian in goat cheeses was evaluated by chemical and sensory analysis. The chemical composition of cheeses was analyzed by HS-SPME-GC-MS (Head-Space—Solid Phase MicroExtraction—Gas Chromatography—Mass Spectrometry) for volatile compounds (alcohols, ketones, aldehydes, esters, alkenes, alkanes, acids, terpenes) and UHPLC-DAD (Ultra High-Performance Liquid Chromatography—Diode Array Detector) for gentian bitter compounds (seco-iridoids). The sensory analysis consisted of a bitterness rating and a free description of cheeses by 17 trained panelists. Results of the study highlighted that unflavored goat cheeses presented higher unpleasant notes (goaty and lactic whey) and higher amounts of hexanoic acid and toluene compared to gentian flavored goat cheeses. The bitterness of gentian flavored goat cheeses was higher compared to unflavored cheeses and could be explained by loganic acid transfer from yellow gentian to flavored cheeses. Other free descriptors of gentian flavored goat cheeses revealed more complex notes (herbal, vegetal, floral, sweet, spicy and creamy) and higher relative amounts of volatile compounds such as 3-methyl butanoic acid, 2-methyl propanoic acid, 4-methyl decane, 2,3-butanediol, ethanol, diacetyl, methyl acetate and 2-phenylethyl acetate, compared to unflavored cheeses. Phenylethyl acetate was the only volatile compound that enabled differentiation of gentian origin on gentian flavored goat cheeses. Gentian rhizomes could be considered a promising flavoring agent contributing to the olfactive and gustative complexity of flavored goat cheeses and the reduction of their goaty perceptions. Full article
(This article belongs to the Special Issue Current Research on Flavor Compounds in Fermented Food Products)
Show Figures

Graphical abstract

14 pages, 3701 KiB  
Article
Anti-Osteoarthritic Effects of Prunella Vulgaris and Gentiana Lutea In Vitro and In Vivo
by Jeonghyun Kim, Chang-Gun Lee, Seokjin Hwang, Seung-Hee Yun, Laxmi Prasad Uprety, Kang-Il Oh, Shivani Singh, Jisu Yoo, Hyesoo Jeong, Yoonjoong Yong, Subin Yeo, Eunkuk Park and Seon-Yong Jeong
Antioxidants 2023, 12(1), 47; https://doi.org/10.3390/antiox12010047 - 26 Dec 2022
Cited by 3 | Viewed by 2856
Abstract
Osteoarthritis (OA) is the progressive destruction of articular cartilage with severe symptoms, including pain and stiffness. We investigated the anti-osteoarthritic effects of Prunella vulgaris (PV) and Gentiana lutea (GL) extract in primary cultured chondrocytes RAW 264.7 cells in vitro and destabilization of the [...] Read more.
Osteoarthritis (OA) is the progressive destruction of articular cartilage with severe symptoms, including pain and stiffness. We investigated the anti-osteoarthritic effects of Prunella vulgaris (PV) and Gentiana lutea (GL) extract in primary cultured chondrocytes RAW 264.7 cells in vitro and destabilization of the medial meniscus (DMM)-induced OA mice in vivo. Primary chondrocytes were induced with IL-1β, and RAW 264.7 cells were treated with LPS and co-incubated with either individual extracts of PV and GL or different ratios of PV and GL mixture. For the OA animal model, the medial meniscus (DMM) was destabilized in 9-week-old male C57BL/6 mice. Treatment of individual PV and GL and combination of PV and GL extracts inhibited the mRNA expression level of COX2 in chondrocytes and RAW 264.7 cells. The optimized inhibitory effect was attained with a PV and GL combination at an 8:2 ratio (PG) without cytotoxic effects. PG extracts prevented the expression of catabolic factors (COX2, Mmp3, Mmp9, and Mmp13) and inflammatory mediator levels (PGE2 and collagenase). In addition, PG decreased subchondral sclerosis and increased BMD in the subchondral region of DMM-induced OA mice with protection of articular cartilage destruction by inhibiting inflammatory processes. This study suggests that PG may be an alternative medicinal herb for treatment of OA. Full article
Show Figures

Figure 1

24 pages, 1890 KiB  
Article
Traditional Ethnobotanical Knowledge of the Central Lika Region (Continental Croatia)—First Record of Edible Use of Fungus Taphrina pruni
by Ivana Vitasović-Kosić, Antonija Hodak, Łukasz Łuczaj, Mara Marić and Josip Juračak
Plants 2022, 11(22), 3133; https://doi.org/10.3390/plants11223133 - 16 Nov 2022
Cited by 11 | Viewed by 3378
Abstract
This study analyzed the use of plants and fungi, some wild and some cultivated, in three municipalities of Lika-Senj County (Perušić, Gospić and Lovinac). The range of the study area was about 60 km. Forty in-depth semi-structured interviews were performed. The use of [...] Read more.
This study analyzed the use of plants and fungi, some wild and some cultivated, in three municipalities of Lika-Senj County (Perušić, Gospić and Lovinac). The range of the study area was about 60 km. Forty in-depth semi-structured interviews were performed. The use of 111 plant taxa from 50 plant families and five taxa of mushrooms and fungi belonging to five families was recorded (on average 27 taxa per interview). The results showed quite large differences between the three studied areas in terms of ethnobotanical and ecological knowledge. In the Perušić area, (101 taxa mentioned), some people still use wild plants on a daily basis for various purposes. The most commonly noted plants are Prunus spinosa, Taraxacum spp., Rosa canina, Urtica dioica, Juglans regia and Fragaria vesca. In the Lovinac region, people used fewer species of plants (76 species mentioned). The most common species used there are: Rosa canina, Achillea millefolium, Cornus mas, Crataegus monogyna, Sambucus nigra and Prunus domestica. In the town of Gospić, the collection and use of plants was not so widespread, with only 61 species mentioned, the most common being: Achillea millefolium, Cornus mas, Sambucus nigra, Viola sp., Prunus domestica and Rosa canina. The medicinal use of herbal tea Rubus caesius and Cydonia oblonga against diarrhea was well known in the study area and is used medicinally, mainly in the rural parts of the Gospić area. The consumption of the Sorbus species (S. aria, S. domestica and S. torminalis) is an interesting local tradition in Perušić and Lovinac. Species that are difficult to find in nature today and are no longer used include: Veratrum sp., Rhamnus alpinum ssp. fallax, Gentiana lutea and Ribes uva-crispa. The use of Chenopodium album has also died out. We can assume that the differences in ethnobotanical knowledge between the three studied areas are partly due to minor differences in climate and topography, while other causes lie in the higher degree of rurality and stronger ties to nature in the Lovinac and Perušić areas. The most important finding of the study is the use of the parasitic fungus Taphrina pruni (Fuckel) Tul. as a snack. The use of Helleborus dumetorum for ethnoveterinary practices is also worth noting. The traditional use of plants in the study area shows many signs of abandonment, and therefore efforts must be made to maintain the knowledge recorded in our study. Full article
(This article belongs to the Section Phytochemistry)
Show Figures

Figure 1

20 pages, 4816 KiB  
Article
Development of Lipid-Based Gastroretentive Delivery System for Gentian Extract by Double Emulsion–Melt Dispersion Technique
by Jelena Mudrić, Katarina Šavikin, Ljiljana Đekić, Stefan Pavlović, Ivana Kurćubić, Svetlana Ibrić and Jelena Đuriš
Pharmaceutics 2021, 13(12), 2095; https://doi.org/10.3390/pharmaceutics13122095 - 6 Dec 2021
Cited by 6 | Viewed by 3712
Abstract
Gentian (Gentiana lutea L., Gentianaceae) root extract (GRE) is used for the treatment of gastrointestinal disorders. However, its bioactive potential is limited in conventional forms due to the low bioavailability and short elimination half-life of the dominant bioactive compound, gentiopicroside. The aim [...] Read more.
Gentian (Gentiana lutea L., Gentianaceae) root extract (GRE) is used for the treatment of gastrointestinal disorders. However, its bioactive potential is limited in conventional forms due to the low bioavailability and short elimination half-life of the dominant bioactive compound, gentiopicroside. The aim of study was to encapsulate GRE in the lipid-based gastroretentive delivery system that could provide high yield and encapsulation efficiency, as well as the biphasic release of gentiopicroside from the tablets obtained by direct compression. Solid lipid microparticles (SLM) loaded with GRE were prepared by freeze-drying double (W/O/W) emulsions, which were obtained by a multiple emulsion–melt dispersion technique, with GRE as the inner water phase, Gelucire® 39/01 or 43/01, as lipid components, with or without the addition of porous silica (Sylysia® 350) in the outer water phase. Formulated SLM powders were examined by SEM and mercury intrusion porosimetry, as well as by determination of yield, encapsulation efficiency, and flow properties. Furthermore, in vitro dissolution of gentiopicroside, the size of the dispersed systems, mechanical properties, and mucoadhesion of tablets obtained by direct compression were investigated. The results have revealed that SLM with the macroporous structure were formulated, and, consequently, the powders floated immediately in the acidic medium. Formulation with porous silica (Sylysia® 350) and Gelucire® 43/01 as a solid lipid was characterized with the high yield end encapsulation efficiency. Furthermore, the mucoadhesive properties of tablets obtained by direct compression of that formulation, as well as the biphasic release of gentiopicroside, presence of nanoassociates in dissolution medium, and optimal mechanical properties indicated that a promising lipid-based gastroretentive system for GRE was developed. Full article
(This article belongs to the Section Drug Delivery and Controlled Release)
Show Figures

Graphical abstract

18 pages, 9321 KiB  
Article
Biological Profile of Two Gentiana lutea L. Metabolites Using Computational Approaches and In Vitro Tests
by Simona De Vita, Maria Giovanna Chini, Gabriella Saviano, Claudia Finamore, Carmen Festa, Gianluigi Lauro, Simona De Marino, Roberto Russo, Carmen Avagliano, Agostino Casapullo, Antonio Calignano, Giuseppe Bifulco and Maria Iorizzi
Biomolecules 2021, 11(10), 1490; https://doi.org/10.3390/biom11101490 - 9 Oct 2021
Cited by 6 | Viewed by 3224
Abstract
Natural products have been the main source of bioactive molecules for centuries. We tested the biological profile of two metabolites extracted from Gentiana lutea L. by means of computational techniques and in vitro assays. The two molecules (loganic acid and gentiopicroside) were tested [...] Read more.
Natural products have been the main source of bioactive molecules for centuries. We tested the biological profile of two metabolites extracted from Gentiana lutea L. by means of computational techniques and in vitro assays. The two molecules (loganic acid and gentiopicroside) were tested in silico using an innovative technique, named Inverse Virtual Screening (IVS), to highlight putative partners among a panel of proteins involved in inflammation and cancer events. A positive binding with cyclooxygenase-2 (COX-2), alpha-1-antichymotrypsin, and alpha-1-acid glycoprotein emerged from the computational experiments and the outcomes from the promising interaction with COX-2 were confirmed by Western blot, highlighting the reliability of IVS in the field of the natural products. Full article
Show Figures

Graphical abstract

10 pages, 280 KiB  
Article
Phenolics of Aerial Parts of Gentiana lutea L. and Their Biological Activity
by Erna Karalija, Sanja Ćavar Zeljković, Sabina Dahija, Renata Bešta-Gajević and Adisa Parić
Agronomy 2021, 11(7), 1442; https://doi.org/10.3390/agronomy11071442 - 20 Jul 2021
Cited by 6 | Viewed by 3363
Abstract
Gentiana lutea L. is a medicinal plant the roots of which are primarily used in treatments of various human digestive disorders, but also the production of alcoholic liquors. The roots (radix) of G. lutea are described in the European Pharmacopeia, but knowledge about [...] Read more.
Gentiana lutea L. is a medicinal plant the roots of which are primarily used in treatments of various human digestive disorders, but also the production of alcoholic liquors. The roots (radix) of G. lutea are described in the European Pharmacopeia, but knowledge about the chemical composition and biological activities of its aerial parts is still limited. Thus, until today aerial parts of this species have not been used in medical treatments or consumed. Therefore, flowers, leaves, and stems extracts of G. lutea obtained by using four different extraction solvents (petrol ether, chloroform, ethanol, and water) were examined for their chemical composition and biological activities. High concentrations of salicylic acid, apigenin, and naringenin were recorded for ethanol stem extracts, while significant amounts of kaempferol were detected in leaves and flowers in chloroform and water extracts, respectively. The highest antioxidant potential was recorded for flower and stem petrol ether extracts with the lowest IC50 values, ranging from 94.46 ± 9.45 to 105.38 ± 10.54 μg/mL. Ethanol extracts of flowers and stems showed moderate antioxidant activity (IC50 143.15 ± 14.32 and 146.90 ± 14.69 μg/mL) as well as strong antimicrobial activity against Candida albicans (21.00 ± 1.00 and 27.50 ± 1.78 mm inhibition zones, respectively). In addition, ethanol extracts had higher antimycotic activity compared to naturally occurring phenolic compounds that are used as positive controls. Moreover, statistical analysis of the activities of plant extracts and single compounds showed that levels of chlorogenic and caffeic acids strongly correlate with the biological activities of the extracts, i.e., they are the main carriers of these biological activities. The presented results indicate the possible use of aerial parts of G. lutea as a natural preservative, as well as a antimicrobial agent, which significantly amplifies the benefits of this medicinal crop and greatly affects the sustainability of cultivated Gentiana plantation. Full article
11 pages, 2797 KiB  
Article
Osteoprotective Effects of Loganic Acid on Osteoblastic and Osteoclastic Cells and Osteoporosis-Induced Mice
by Eunkuk Park, Chang Gun Lee, Eunguk Lim, Seokjin Hwang, Seung Hee Yun, Jeonghyun Kim, Hyesoo Jeong, Yoonjoong Yong, Seong-Hoon Yun, Chun Whan Choi, Hyun-Seok Jin and Seon-Yong Jeong
Int. J. Mol. Sci. 2021, 22(1), 233; https://doi.org/10.3390/ijms22010233 - 28 Dec 2020
Cited by 31 | Viewed by 3758
Abstract
Osteoporosis is a common disease caused by an imbalance of processes between bone resorption by osteoclasts and bone formation by osteoblasts in postmenopausal women. The roots of Gentiana lutea L. (GL) are reported to have beneficial effects on various human diseases related to [...] Read more.
Osteoporosis is a common disease caused by an imbalance of processes between bone resorption by osteoclasts and bone formation by osteoblasts in postmenopausal women. The roots of Gentiana lutea L. (GL) are reported to have beneficial effects on various human diseases related to liver functions and gastrointestinal motility, as well as on arthritis. Here, we fractionated and isolated bioactive constituent(s) responsible for anti-osteoporotic effects of GL root extract. A single phytochemical compound, loganic acid, was identified as a candidate osteoprotective agent. Its anti-osteoporotic effects were examined in vitro and in vivo. Treatment with loganic acid significantly increased osteoblastic differentiation in preosteoblast MC3T3-E1 cells by promoting alkaline phosphatase activity and increasing mRNA expression levels of bone metabolic markers such as Alpl, Bglap, and Sp7. However, loganic acid inhibited osteoclast differentiation of primary-cultured monocytes derived from mouse bone marrow. For in vivo experiments, the effect of loganic acid on ovariectomized (OVX) mice was examined for 12 weeks. Loganic acid prevented OVX-induced bone mineral density loss and improved bone structural properties in osteoporotic model mice. These results suggest that loganic acid may be a potential therapeutic candidate for treatment of osteoporosis. Full article
(This article belongs to the Special Issue Bone Metastasis Challenge: New Ideas and Future Perspectives)
Show Figures

Figure 1

Back to TopTop